company background image
4142 logo

Adimmune TWSE:4142 Stock Report

Last Price

NT$26.50

Market Cap

NT$11.2b

7D

-0.2%

1Y

-32.8%

Updated

28 Mar, 2024

Data

Company Financials

4142 Stock Overview

Adimmune Corporation manufactures and sells human vaccines in Taiwan.

4142 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 4142 from our risk checks.

Adimmune Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Adimmune
Historical stock prices
Current Share PriceNT$26.50
52 Week HighNT$41.25
52 Week LowNT$26.20
Beta0.46
1 Month Change-10.62%
3 Month Change-20.06%
1 Year Change-32.83%
3 Year Change-53.91%
5 Year Change29.90%
Change since IPO-62.14%

Recent News & Updates

Recent updates

Shareholders Can Be Confident That Adimmune's (TPE:4142) Earnings Are High Quality

Apr 05
Shareholders Can Be Confident That Adimmune's (TPE:4142) Earnings Are High Quality

Is Adimmune (TPE:4142) Using Debt In A Risky Way?

Mar 01
Is Adimmune (TPE:4142) Using Debt In A Risky Way?

Introducing Adimmune (TPE:4142), The Stock That Zoomed 158% In The Last Three Years

Jan 07
Introducing Adimmune (TPE:4142), The Stock That Zoomed 158% In The Last Three Years

Shareholder Returns

4142TW BiotechsTW Market
7D-0.2%1.2%-0.3%
1Y-32.8%-20.4%25.8%

Return vs Industry: 4142 underperformed the TW Biotechs industry which returned -21.1% over the past year.

Return vs Market: 4142 underperformed the TW Market which returned 26.7% over the past year.

Price Volatility

Is 4142's price volatile compared to industry and market?
4142 volatility
4142 Average Weekly Movement2.2%
Biotechs Industry Average Movement4.3%
Market Average Movement4.2%
10% most volatile stocks in TW Market8.1%
10% least volatile stocks in TW Market1.9%

Stable Share Price: 4142's share price has been volatile over the past 3 months.

Volatility Over Time: 4142's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1965564Steve Chanhttps://www.adimmune.com.tw

Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd.

Adimmune Corporation Fundamentals Summary

How do Adimmune's earnings and revenue compare to its market cap?
4142 fundamental statistics
Market capNT$11.17b
Earnings (TTM)-NT$165.25m
Revenue (TTM)NT$1.81b

6.2x

P/S Ratio

-67.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4142 income statement (TTM)
RevenueNT$1.81b
Cost of RevenueNT$1.24b
Gross ProfitNT$568.97m
Other ExpensesNT$734.22m
Earnings-NT$165.25m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.39
Gross Margin31.43%
Net Profit Margin-9.13%
Debt/Equity Ratio42.7%

How did 4142 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.